Yousif Capital Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.59M Sell
129,836
-7,118
-5% -$210K 0.05% 331
2026
Q1
$3.79M Sell
136,954
-2,598
-2% -$66.7K 0.04% 385
2025
Q4
$3.21M Buy
139,552
+1,327
+1% +$26.2K 0.04% 484
2025
Q3
$2.09M Sell
138,225
-6,564
-5% -$81.3K 0.02% 696
2025
Q2
$1.63M Sell
144,789
-4,102
-3% -$44.5K 0.02% 855
2025
Q1
$1.5M Sell
148,891
-7,341
-5% -$79.4K 0.02% 881
2024
Q4
$1.85M Sell
156,232
-8,909
-5% -$105K 0.02% 803
2024
Q3
$1.91M Buy
165,141
+19,649
+14% +$224K 0.02% 793
2024
Q2
$1.54M Buy
145,492
+33,530
+30% +$367K 0.02% 892
2024
Q1
$1.18M Buy
+111,962
New +$1.21M 0.01% 1117

Other funds holding ROIV

Yousif Capital Management's ROIV Position: Q2 2026 in Review

Yousif Capital Management reduced its Roivant Sciences (ROIV) stake by 5.2% in Q2 2026, selling an estimated $210K and leaving 129,836 shares worth $4.59M. The position accounts for 0.05% of the portfolio, ranked #331.

Yousif Capital Management first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Yousif Capital Management held 129,836 shares of Roivant Sciences worth $4.59M as of Q2 2026.
  • Yousif Capital Management sold 7,118 Roivant Sciences shares in Q2 2026, an estimated $210K.
  • Roivant Sciences made up 0.05% of Yousif Capital Management's portfolio in Q2 2026, its #331 holding.
  • Yousif Capital Management first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.